Market is currently closed. Voting is open during market hours.
60 Degrees Pharmaceuticals, Inc. announced the enrollment of the first patient in an expanded access study (NCT06478641) assessing the effectiveness of tafenoquine in treating patients with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback